- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this latest study, the 2020 growth of Human Vaccine will have significant change from previous year. By the most conservative estimates of global Human Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Human Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Adults
Children
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Vaccine Consumption 2016-2026
2.1.2 Human Vaccine Consumption CAGR by Region
2.2 Human Vaccine Segment by Type
2.2.1 Varicella
2.2.2 Influenza
2.2.3 Polio
2.2.4 Hepatitis A
2.2.5 Rabies
2.2.6 BCG
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, Tetanus
2.2.9 Pneumococcal
2.2.10 Rota vaccine
2.3 Human Vaccine Sales by Type
2.3.1 Global Human Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Human Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Human Vaccine Sale Price by Type (2016-2021)
2.4 Human Vaccine Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Human Vaccine Sales by Application
2.5.1 Global Human Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Human Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Human Vaccine Sale Price by Application (2016-2021)
3 Global Human Vaccine by Company
3.1 Global Human Vaccine Sales Market Share by Company
3.1.1 Global Human Vaccine Sales by Company (2019-2021)
3.1.2 Global Human Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Human Vaccine Revenue Market Share by Company
3.2.1 Global Human Vaccine Revenue by Company (2019-2021)
3.2.2 Global Human Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Human Vaccine Sale Price by Company
3.4 Global Manufacturers Human Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Vaccine Product Location Distribution
3.4.2 Players Human Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Human Vaccine by Region
4.1 Global Human Vaccine by Region
4.1.1 Global Human Vaccine Sales by Region
4.1.2 Global Human Vaccine Revenue by Region
4.2 Americas Human Vaccine Sales Growth
4.3 APAC Human Vaccine Sales Growth
4.4 Europe Human Vaccine Sales Growth
4.5 Middle East & Africa Human Vaccine Sales Growth
5 Americas
5.1 Americas Human Vaccine Sales by Country
5.1.1 Americas Human Vaccine Sales by Country (2016-2021)
5.1.2 Americas Human Vaccine Revenue by Country (2016-2021)
5.2 Americas Human Vaccine Sales by Type
5.3 Americas Human Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Vaccine Sales by Region
6.1.1 APAC Human Vaccine Sales by Region (2016-2021)
6.1.2 APAC Human Vaccine Revenue by Region (2016-2021)
6.2 APAC Human Vaccine Sales by Type
6.3 APAC Human Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Human Vaccine by Country
7.1.1 Europe Human Vaccine Sales by Country (2016-2021)
7.1.2 Europe Human Vaccine Revenue by Country (2016-2021)
7.2 Europe Human Vaccine Sales by Type
7.3 Europe Human Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Vaccine by Country
8.1.1 Middle East & Africa Human Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Human Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Human Vaccine Sales by Type
8.3 Middle East & Africa Human Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Vaccine Distributors
10.3 Human Vaccine Customer
11 Global Human Vaccine Market Forecast
11.1 Global Human Vaccine Forecast by Region
11.1.1 Global Human Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Human Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Human Vaccine Forecast by Type
11.7 Global Human Vaccine Forecast by Application
12 Key Players Analysis
12.1 CNBG
12.1.1 CNBG CNBG Company Information
12.1.2 CNBG Human Vaccine Product Offered
12.1.3 CNBG Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 CNBG Main Business Overview
12.1.5 CNBG Latest Developments
12.2 Changsheng Life
12.2.1 Changsheng Life Company Information
12.2.2 Changsheng Life Human Vaccine Product Offered
12.2.3 Changsheng Life Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Changsheng Life Main Business Overview
12.2.5 Changsheng Life Latest Developments
12.3 Zhifei
12.3.1 Zhifei Company Information
12.3.2 Zhifei Human Vaccine Product Offered
12.3.3 Zhifei Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Zhifei Main Business Overview
12.3.5 Zhifei Latest Developments
12.4 ChengDa Bio
12.4.1 ChengDa Bio Company Information
12.4.2 ChengDa Bio Human Vaccine Product Offered
12.4.3 ChengDa Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 ChengDa Bio Main Business Overview
12.4.5 ChengDa Bio Latest Developments
12.5 Kangtai
12.5.1 Kangtai Company Information
12.5.2 Kangtai Human Vaccine Product Offered
12.5.3 Kangtai Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Kangtai Main Business Overview
12.5.5 Kangtai Latest Developments
12.6 SINOVAC BIOTECH
12.6.1 SINOVAC BIOTECH Company Information
12.6.2 SINOVAC BIOTECH Human Vaccine Product Offered
12.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 SINOVAC BIOTECH Main Business Overview
12.6.5 SINOVAC BIOTECH Latest Developments
12.7 Hissen
12.7.1 Hissen Company Information
12.7.2 Hissen Human Vaccine Product Offered
12.7.3 Hissen Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Hissen Main Business Overview
12.7.5 Hissen Latest Developments
12.8 Walvax Biotechnology
12.8.1 Walvax Biotechnology Company Information
12.8.2 Walvax Biotechnology Human Vaccine Product Offered
12.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Walvax Biotechnology Main Business Overview
12.8.5 Walvax Biotechnology Latest Developments
12.9 GSK
12.9.1 GSK Company Information
12.9.2 GSK Human Vaccine Product Offered
12.9.3 GSK Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 GSK Main Business Overview
12.9.5 GSK Latest Developments
12.10 SANOFI
12.10.1 SANOFI Company Information
12.10.2 SANOFI Human Vaccine Product Offered
12.10.3 SANOFI Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 SANOFI Main Business Overview
12.10.5 SANOFI Latest Developments
12.11 Rong An
12.11.1 Rong An Company Information
12.11.2 Rong An Human Vaccine Product Offered
12.11.3 Rong An Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Rong An Main Business Overview
12.11.5 Rong An Latest Developments
12.12 NuoCheng Bio
12.12.1 NuoCheng Bio Company Information
12.12.2 NuoCheng Bio Human Vaccine Product Offered
12.12.3 NuoCheng Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 NuoCheng Bio Main Business Overview
12.12.5 NuoCheng Bio Latest Developments
12.13 Hualan Bio
12.13.1 Hualan Bio Company Information
12.13.2 Hualan Bio Human Vaccine Product Offered
12.13.3 Hualan Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Hualan Bio Main Business Overview
12.13.5 Hualan Bio Latest Developments
12.14 Tiantan biological
12.14.1 Tiantan biological Company Information
12.14.2 Tiantan biological Human Vaccine Product Offered
12.14.3 Tiantan biological Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Tiantan biological Main Business Overview
12.14.5 Tiantan biological Latest Developments
12.15 Changchun Baike
12.15.1 Changchun Baike Company Information
12.15.2 Changchun Baike Human Vaccine Product Offered
12.15.3 Changchun Baike Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Changchun Baike Main Business Overview
12.15.5 Changchun Baike Latest Developments
12.16 Adimmune
12.16.1 Adimmune Company Information
12.16.2 Adimmune Human Vaccine Product Offered
12.16.3 Adimmune Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Adimmune Main Business Overview
12.16.5 Adimmune Latest Developments
12.17 Zhongyianke Biotech
12.17.1 Zhongyianke Biotech Company Information
12.17.2 Zhongyianke Biotech Human Vaccine Product Offered
12.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Zhongyianke Biotech Main Business Overview
12.17.5 Zhongyianke Biotech Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Human Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Varicella
Table 3. Major Players of Influenza
Table 4. Major Players of Polio
Table 5. Major Players of Hepatitis A
Table 6. Major Players of Rabies
Table 7. Major Players of BCG
Table 8. Major Players of Hepatitis B
Table 9. Major Players of Pertussis, Diphtheria, Tetanus
Table 10. Major Players of Pneumococcal
Table 11. Major Players of Rota vaccine
Table 12. Global Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 13. Global Human Vaccine Sales Market Share by Type (2016-2021)
Table 14. Global Human Vaccine Revenue by Type (2016-2021) & ($ million)
Table 15. Global Human Vaccine Revenue Market Share by Type (2016-2021)
Table 16. Global Human Vaccine Sale Price by Type (2016-2021)
Table 17. Global Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 18. Global Human Vaccine Sales Market Share by Application (2016-2021)
Table 19. Global Human Vaccine Value by Application (2016-2021)
Table 20. Global Human Vaccine Revenue Market Share by Application (2016-2021)
Table 21. Global Human Vaccine Sale Price by Application (2016-2021)
Table 22. Global Human Vaccine Sales by Company (2019-2021) & (M Doses)
Table 23. Global Human Vaccine Sales Market Share by Company (2019-2021)
Table 24. Global Human Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 25. Global Human Vaccine Revenue Market Share by Company (2019-2021)
Table 26. Global Human Vaccine Sale Price by Company (2019-2021)
Table 27. Key Manufacturers Human Vaccine Producing Area Distribution and Sales Area
Table 28. Players Human Vaccine Products Offered
Table 29. Human Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global Human Vaccine Sales by Region (2016-2021) (M Doses)
Table 33. Global Human Vaccine Sales Market Share by Region (2016-2021)
Table 34. Global Human Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 35. Global Human Vaccine Revenue Market Share by Region (2016-2021)
Table 36. Americas Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 37. Americas Human Vaccine Sales Market Share by Country (2016-2021)
Table 38. Americas Human Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 39. Americas Human Vaccine Revenue Market Share by Country (2016-2021)
Table 40. Americas Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 41. Americas Human Vaccine Sales Market Share by Type (2016-2021)
Table 42. Americas Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 43. Americas Human Vaccine Sales Market Share by Application (2016-2021)
Table 44. APAC Human Vaccine Sales by Region (2016-2021) & (M Doses)
Table 45. APAC Human Vaccine Sales Market Share by Region (2016-2021)
Table 46. APAC Human Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 47. APAC Human Vaccine Revenue Market Share by Region (2016-2021)
Table 48. APAC Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 49. APAC Human Vaccine Sales Market Share by Type (2016-2021)
Table 50. APAC Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 51. APAC Human Vaccine Sales Market Share by Application (2016-2021)
Table 52. Europe Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 53. Europe Human Vaccine Sales Market Share by Country (2016-2021)
Table 54. Europe Human Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 55. Europe Human Vaccine Revenue Market Share by Country (2016-2021)
Table 56. Europe Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 57. Europe Human Vaccine Sales Market Share by Type (2016-2021)
Table 58. Europe Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Human Vaccine Sales Market Share by Application (2016-2021)
Table 60. Middle East & Africa Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 61. Middle East & Africa Human Vaccine Sales Market Share by Country (2016-2021)
Table 62. Middle East & Africa Human Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 63. Middle East & Africa Human Vaccine Revenue Market Share by Country (2016-2021)
Table 64. Middle East & Africa Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 65. Middle East & Africa Human Vaccine Sales Market Share by Type (2016-2021)
Table 66. Middle East & Africa Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 67. Middle East & Africa Human Vaccine Sales Market Share by Application (2016-2021)
Table 68. Global Human Vaccine Sales Forecast by Type (2021-2026) & (M Doses)
Table 69. Global Human Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 70. Global Human Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 71. Global Human Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 72. Global Human Vaccine Sales Forecast by Application (2021-2026) & (M Doses)
Table 73. Global Human Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 74. Global Human Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 75. Global Human Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 76. CNBG Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 77. CNBG Human Vaccine Product Offered
Table 78. CNBG Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 79. CNBG Main Business
Table 80. CNBG Latest Developments
Table 81. Changsheng Life Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 82. Changsheng Life Human Vaccine Product Offered
Table 83. Changsheng Life Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 84. Changsheng Life Main Business
Table 85. Changsheng Life Latest Developments
Table 86. Zhifei Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. Zhifei Human Vaccine Product Offered
Table 88. Zhifei Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 89. Zhifei Main Business
Table 90. Zhifei Latest Developments
Table 91. ChengDa Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. ChengDa Bio Human Vaccine Product Offered
Table 93. ChengDa Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 94. ChengDa Bio Main Business
Table 95. ChengDa Bio Latest Developments
Table 96. Kangtai Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. Kangtai Human Vaccine Product Offered
Table 98. Kangtai Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 99. Kangtai Main Business
Table 100. Kangtai Latest Developments
Table 101. SINOVAC BIOTECH Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. SINOVAC BIOTECH Human Vaccine Product Offered
Table 103. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 104. SINOVAC BIOTECH Main Business
Table 105. SINOVAC BIOTECH Latest Developments
Table 106. Hissen Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. Hissen Human Vaccine Product Offered
Table 108. Hissen Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 109. Hissen Main Business
Table 110. Hissen Latest Developments
Table 111. Walvax Biotechnology Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. Walvax Biotechnology Human Vaccine Product Offered
Table 113. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 114. Walvax Biotechnology Main Business
Table 115. Walvax Biotechnology Latest Developments
Table 116. GSK Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 117. GSK Human Vaccine Product Offered
Table 118. GSK Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 119. GSK Main Business
Table 120. GSK Latest Developments
Table 121. SANOFI Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 122. SANOFI Human Vaccine Product Offered
Table 123. SANOFI Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 124. SANOFI Main Business
Table 125. SANOFI Latest Developments
Table 126. Rong An Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 127. Rong An Human Vaccine Product Offered
Table 128. Rong An Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 129. Rong An Main Business
Table 130. Rong An Latest Developments
Table 131. NuoCheng Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 132. NuoCheng Bio Human Vaccine Product Offered
Table 133. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 134. NuoCheng Bio Main Business
Table 135. NuoCheng Bio Latest Developments
Table 136. Hualan Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 137. Hualan Bio Human Vaccine Product Offered
Table 138. Hualan Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 139. Hualan Bio Main Business
Table 140. Hualan Bio Latest Developments
Table 141. Tiantan biological Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 142. Tiantan biological Human Vaccine Product Offered
Table 143. Tiantan biological Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 144. Tiantan biological Main Business
Table 145. Tiantan biological Latest Developments
Table 146. Changchun Baike Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 147. Changchun Baike Human Vaccine Product Offered
Table 148. Changchun Baike Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 149. Changchun Baike Main Business
Table 150. Changchun Baike Latest Developments
Table 151. Adimmune Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 152. Adimmune Human Vaccine Product Offered
Table 153. Adimmune Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 154. Adimmune Main Business
Table 155. Adimmune Latest Developments
Table 156. Zhongyianke Biotech Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 157. Zhongyianke Biotech Human Vaccine Product Offered
Table 158. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 159. Zhongyianke Biotech Main Business
Table 160. Zhongyianke Biotech Latest Developments
List of Figures
Figure 1. Picture of Human Vaccine
Figure 2. Human Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Vaccine Sales Growth Rate 2016-2026 (M Doses)
Figure 7. Global Human Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Human Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Varicella
Figure 10. Product Picture of Influenza
Figure 11. Product Picture of Polio
Figure 12. Product Picture of Hepatitis A
Figure 13. Product Picture of Rabies
Figure 14. Product Picture of BCG
Figure 15. Product Picture of Hepatitis B
Figure 16. Product Picture of Pertussis, Diphtheria, Tetanus
Figure 17. Product Picture of Pneumococcal
Figure 18. Product Picture of Rota vaccine
Figure 19. Global Human Vaccine Sales Market Share by Type in 2020
Figure 20. Global Human Vaccine Revenue Market Share by Type (2016-2021)
Figure 21. Human Vaccine Consumed in Adults
Figure 22. Global Human Vaccine Market: Adults (2016-2021) & (M Doses)
Figure 23. Human Vaccine Consumed in Children
Figure 24. Global Human Vaccine Market: Children (2016-2021) & (M Doses)
Figure 25. Global Human Vaccine Sales Market Share by Application (2016-2021)
Figure 26. Global Human Vaccine Revenue Market Share by Application in 2020
Figure 27. Global Human Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 28. Global Human Vaccine Revenue Market Share by Company in 2020
Figure 29. Global Human Vaccine Sales Market Share by Regions (2016-2021)
Figure 30. Global Human Vaccine Revenue Market Share by Region in 2020
Figure 31. Americas Human Vaccine Sales 2016-2021 (M Doses)
Figure 32. Americas Human Vaccine Revenue 2016-2021 ($ Millions)
Figure 33. APAC Human Vaccine Sales 2016-2021 (M Doses)
Figure 34. APAC Human Vaccine Revenue 2016-2021 ($ Millions)
Figure 35. Europe Human Vaccine Sales 2016-2021 (M Doses)
Figure 36. Europe Human Vaccine Revenue 2016-2021 ($ Millions)
Figure 37. Middle East & Africa Human Vaccine Sales 2016-2021 (M Doses)
Figure 38. Middle East & Africa Human Vaccine Revenue 2016-2021 ($ Millions)
Figure 39. Americas Human Vaccine Sales Market Share by Country in 2020
Figure 40. Americas Human Vaccine Revenue Market Share by Country in 2020
Figure 41. Americas Human Vaccine Sales Market Share by Type in 2020
Figure 42. Americas Human Vaccine Sales Market Share by Application in 2020
Figure 43. United States Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 44. Canada Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 45. Mexico Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Brazil Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. APAC Human Vaccine Sales Market Share by Region in 2020
Figure 48. APAC Human Vaccine Revenue Market Share by Regions in 2020
Figure 49. APAC Human Vaccine Sales Market Share by Type in 2020
Figure 50. APAC Human Vaccine Sales Market Share by Application in 2020
Figure 51. China Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 52. Japan Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 53. Korea Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 54. Southeast Asia Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 55. India Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. Australia Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. Europe Human Vaccine Sales Market Share by Country in 2020
Figure 58. Europe Human Vaccine Revenue Market Share by Country in 2020
Figure 59. Europe Human Vaccine Sales Market Share by Type in 2020
Figure 60. Europe Human Vaccine Sales Market Share by Application in 2020
Figure 61. Germany Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 62. France Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 63. UK Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 64. Italy Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. Russia Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Middle East & Africa Human Vaccine Sales Market Share by Country in 2020
Figure 67. Middle East & Africa Human Vaccine Revenue Market Share by Country in 2020
Figure 68. Middle East & Africa Human Vaccine Sales Market Share by Type in 2020
Figure 69. Middle East & Africa Human Vaccine Sales Market Share by Application in 2020
Figure 70. Egypt Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 71. South Africa Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 72. Israel Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 73. Turkey Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 74. GCC Country Human Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Please feel free to write an email to us or to use our electronic ticketing system.
